finwire.io
Insider Trading News

10% owner Venrock Healthcare Capital Partners III, L.P. buys $223,820 of Lycia Therapeutics, Inc. stock

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
10% owner Venrock Healthcare Capital Partners III, L.P. buys $223,820 of Lycia Therapeutics, Inc. stock10% owner Venrock Healthcare Capital Partners III, L.P. buys $223,820 of Lycia Therapeutics, Inc. stock

An open-market purchase on Nov 2, reported to the SEC on Nov 4. Information only, not investment advice.

A Form 4 filed on Nov 4 shows Venrock Healthcare Capital Partners III, L.P., a holder of more than 10% of Lycia Therapeutics, Inc., buying 8,305 shares worth $223,820 on Nov 2, at about $26.95 each.

The purchase was made in the open market, not through an award, an option exercise or a plan. The trade was reported within two business days, as Section 16 requires.

After the trade, the filing lists 6,858,542 shares held.

Details from the SEC filing:

The purchase
CompanyLycia Therapeutics, Inc. (LYCA)
InsiderVenrock Healthcare Capital Partners III, L.P.
Role10% owner
TransactionOpen-market purchase (code P)
Shares8,305
Average price$26.95
Value$223,820
Trade dateNov 2, 2026
Filed with the SECNov 4, 2026, 5:12 PM ET
Shares held after6,858,542
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

See every transaction in this Lycia Therapeutics, Inc. filing

View the Form 4 on SEC.gov

See the latest cluster buys and sells · See more large insider purchases

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Related Articles